Rankings
▼
Calendar
DFTX Q1 2017 Earnings — Definium Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
DFTX
Definium Therapeutics, Inc.
$2B
Q1 2017 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$280,280
Net Income
-$278,057
EPS (Diluted)
$-1.35
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$297,681
Free Cash Flow
-$151,600
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$2M
Total Liabilities
$26,944
Stockholders' Equity
$2M
Cash & Equivalents
$116,692
← FY 2017
All Quarters
Q2 2017 →
